Authors: Bonfante, V Viviani, S Devizzi, L Di Russo, A Di Nicola, M Magni, M Matteucci, P Grisanti, S Valagussa, P Bonadonna, G Gianni, AM

Citation: V. Bonfante et al., High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease, EUR J HAEMA, 66, 2001, pp. 51-55

Authors: Santoro, A Bredenfeld, H Devizzi, L Tesch, H Bonfante, V Viviani, S Fielder, F Parra, HS Benoehr, C Pacini, M Bonadonna, G Diehl, V

Citation: A. Santoro et al., Gemcitabine in the treatment of refractory Hodgkins's disease: Results of a multicenter phase II study, J CL ONCOL, 18(13), 2000, pp. 2615-2619

Authors: Magni, M Di Nicola, M Devizzi, L Matteucci, P Lombardi, F Gandola, L Ravagnani, F Giardini, R Dastoli, G Tarella, C Pileri, A Bonadonna, G Gianni, AM

Citation: M. Magni et al., Successful in vivo purging of CD34-containing peripheral blood harvests inmantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion, BLOOD, 96(3), 2000, pp. 864-869

Authors: Viviani, S Bonfante, V Santoro, A Zanini, M Devizzi, L Di Russo, A Soncini, F Villani, F Ragni, G Valagussa, P Bonadonna, G

Citation: S. Viviani et al., Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease, CA J SCI AM, 5(5), 1999, pp. 275-282

Authors: Maffioli, LS Castellani, MR Bombardieri, E Devizzi, L Draisma, A Pauwels, E

Citation: Ls. Maffioli et al., Changing biodistribution of gallium during G-CSF treatment in non-Hodgkin's disease, EUR J NUCL, 26(1), 1999, pp. 68-69